During the past decade, Clinical Sciences Building conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinical Sciences Building" are "Head and Neck Cancer" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Clinical Sciences Building" in a lesser frequency.

Most popular intervention types in "Clinical Sciences Building" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ad5CMV-p53 gene" (1 trials) and "alvocidib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Sciences Building" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Sciences Building". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinical Sciences Building, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Sciences Building, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".